CDC flags neuro symptoms after unapproved botulinum toxin - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

CDC flags neuro symptoms after unapproved botulinum toxin

None of the 3 symptomatic patients knew the injected product lacked FDA approval.

  • By

  • Teraya Smith

  • October 9, 2026

  • 3 min

Share

Clinical Report: CDC flags neuro symptoms after unapproved botulinum toxin

Related Resources & Content

  1. MDSpire News — AAD and CDC Urge Patients to Follow Guidance to Avoid Counterfeit Botox Injectables
  2. Open Forum Infectious Diseases — Botulism Sequelae: A Systematic Review
  3. MDSpire News — When Constipation Signals Something More
  4. Associated Press Health — FDA issues warning to 18 websites selling unapproved Botox
  5. MMWR, Volume 75, Issue 39 — October 6, 2026
  6. Clinical Guidelines for Diagnosis and Treatment of Botulism, 2021
  7. MMWR, Volume 73, Issue 27 — July 11, 2024

Original Source(s)

CDC flags neuro symptoms after unapproved botulinum toxin

  • by Teraya Smith

  • October 9, 2026

Related Content

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Safety and Efficacy of OBI-858 in Patients with Moderate-to-Severe Glabellar Lines

Assessment of Safety and Effectiveness of Combined Platelet-Rich Plasma and Hyaluronic Acid Therapy for Neck Rejuvenation in Thailand: A Prospective Investigation

Consensus Guidelines for Dermocosmetic Ingredient Selection in Common Dermatological Situations in Egypt: A RAND/UCLA Appropriateness Assessment